When diagnosed with a disease, it’s often overwhelming to sort through mountains of medical data to figure out what therapies are available, pinpoint where they’re offered and identify the best experts to help. Complexity specialist Gunjan Bhardwaj recognizes that mining this information may best be done using a system of artificial intelligence and blockchain to help people, within and outside the medical field, navigate and comprehend such “deep, dense and diverse” data — entering a new era where all research is searchable and shareable.
Gunjan Bhardwaj studied at IIT Bombay, FH Pforzheim, MIT Sloan and EBS Oestrich-Winkel. He founded Innoplexus in 2011, a technology and product development company focused on solving challenges in life sciences and pharmaceuticals using artificial intelligence. Previously, he worked for BCG and EY. He has authored numerous articles for the Harvard Business Review, the MIT Sloan Review and other journals, and has advised businesses and nonprofit organizations. He lectures at the Frankfurt School of Finance and other schools.
Innoplexus, a leading AI and Life Sciences company, raises double-digit million dollar series C round from FinLab EOS VC and others
Frankfurt, Germany – Innoplexus AG, a leading global artificial intelligence (AI) company with over 80 patent applications in AI, machine learning and blockchain technologies, has received series C funding in the sum of double-digit millions. The round was co-led by FinLab EOS VC Fund, a venture capital fund backed by both Block.one, the publisher of the blockchain protocol EOSIO, and FinLab AG, one of Europe’s largest company builders and investors focused on financial services technologies. The FinLab EOS VC Fund invests across sectors and focuses on projects delivering value through the application of the EOSIO blockchain technology. Innoplexus AG represents FinLab EOS VC Fund’s largest investment to date.
Co-lead investor was existing shareholder ATAI Life Sciences, a global biotech company builder focused on developing breakthrough innovations in mental health. Innoplexus and ATAI closely cooperate to make the drug development process in mental health more effective and efficient by utilizing Innoplexus’ technology.
Innoplexus will use the funding to continue developing its AI and blockchain solutions and for international commercial expansion. “We are pleased to have gained yet another strong investor with the FinLab EOS VC Fund, who will support us to scale even further with their know-how and network,” says Dr. Gunjan Bhardwaj, Founder and CEO of Innoplexus.
Innoplexus’ products & solutions are used by global pharmaceutical and biotechnology companies as well as Clinical Research Organizations generating actionable insights across the drug development life cycle. The company is ushering in a new paradigm in drug discovery and development with its domain specific AI. Innoplexus is working with cutting edge technologies related to information retrieval, network analysis, computer vision, entity normalization and ontologies and has a strong focus on creating proprietary intellectual property.
“We fully believe in the mission of Innoplexus and will support them in transforming drug discovery and development into the areas of AI and blockchain. By integrating the EOSIO protocol, meaningful unpublished data could also be used for research. Innoplexus is leveraging the EOSIO blockchain to integrate unpublished data, as well as information that is trapped in silos, to aggregate growing data oceans and to accelerate drug discovery and development,’’ shares Juan Rodriguez, Managing Director of FinLab EOS VC Fund.
Image Credit: Innoplexus
News This Week
For almost two decades, Stanford electrical engineering professor Krishna Shenoy and neuroscientists in his Neural Prosthetics Translational Laboratory have been working on implantable brain sensors that allow them to record and decipher the electrical [...]
In an incredible first, scientists have captured the world's first actual photo of quantum entanglement - a phenomenon so strange, physicist Albert Einstein famously described it as 'spooky action at a distance'. The image [...]
A team at Flinders University in South Australia has developed a new vaccine believed to be the first human drug in the world to be completely designed by artificial intelligence (AI). While drugs have [...]
Humans routinely send spacecraft into orbit to ensure services on the ground and to explore other planets. This extraordinary ability comes with a great responsibility: our space activity risks contaminating the space surrounding the [...]
Digital information technology has made information readily accessible to practically anyone, anytime and anywhere. This has had a profound effect in shaping all aspects of our society from industrial manufacturing, to distribution, to the [...]
The ways in which the communities of bacteria living within our bodies influence our overall well-being are becoming better understood all the time, and with that better understanding comes potential new ways to intervene [...]
Cancer breakthrough: Scientists discover a new Achilles’ Heel of tumors that causes them to self-destruct
Scientists have identified the Achilles' Heel of cancerous tumors, forcing the disease-spreading cells to over-stress and self-destruct. Experiments showed blocking a specific protein that fuels tumors kills them off. The technique worked on a [...]
Researchers at Oregon State University have developed an improved technique for using magnetic nanoclusters to kill hard-to-reach tumors. Magnetic nanoparticles - tiny pieces of matter as small as one-billionth of a meter - [...]
Plant leaves have a natural superpower — they’re designed with water repelling characteristics. Called a superhydrophobic surface, this trait allows leaves to cleanse themselves from dust particles. Inspired by such natural designs, a [...]
In a grainy black-and-white video shot at the Mayo Clinic in Minnesota, a patient sits in a hospital bed, his head wrapped in a bandage. He’s trying to recall 12 words for a memory [...]
From Frontiers Forum: How can research translate to R&D? Or a whole new business venture? In a panel session at Science Unlimited 2019, Holtzbrinck Publishing Group CEO Stefan von Holtzbrinck, Life Biosciences CEO [...]
More and more security holes are appearing in cryptocurrency and smart contract platforms, and some are fundamental to the way they were built. Early last month, the security team at Coinbase noticed something strange [...]
“The most crucial result of this work is the correlation between form and function in supercapacitor materials,” states first author Dina Ibrahim Abouelamaiem. She elaborates that “our research is driven by the need for [...]